{"id":"fexofenadine-hcl-m016455","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Headache"},{"rate":"5-10%","effect":"Dizziness"},{"rate":"5-10%","effect":"Nausea"},{"rate":"5-10%","effect":"Fatigue"},{"rate":"5-10%","effect":"Dry mouth"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Fexofenadine HCL is a non-sedating antihistamine that selectively inhibits peripheral H1-receptors. This results in the relief of symptoms associated with seasonal and perennial allergic rhinitis, such as sneezing, runny nose, and itchy, watery eyes.","oneSentence":"Fexofenadine HCL is an antihistamine that works by blocking the action of histamine, a substance in the body that causes allergy symptoms.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:12:32.147Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Seasonal allergic rhinitis"},{"name":"Perennial allergic rhinitis"}]},"trialDetails":[{"nctId":"NCT03664882","phase":"PHASE3","title":"Study Evaluating the Efficacy and Safety of Fexofenadine in Subjects Suffering From Seasonal Allergic Rhinitis in Presence of Pollutants","status":"COMPLETED","sponsor":"Sanofi","startDate":"2018-09-17","conditions":"Rhinitis Seasonal","enrollment":240},{"nctId":"NCT01244230","phase":"PHASE2, PHASE3","title":"Safety, Efficacy and Pharmacokinetic Study of Allegra in Pediatric Patients With Atopic Dermatitis (AD)","status":"COMPLETED","sponsor":"Sanofi","startDate":"2010-11","conditions":"Atopic Dermatitis","enrollment":100},{"nctId":"NCT01244217","phase":"PHASE2, PHASE3","title":"Safety, Efficacy and Pharmacokinetic Study of Allegra in Pediatric Patients With Perennial Allergic Rhinitis (PAR)","status":"COMPLETED","sponsor":"Sanofi","startDate":"2010-10","conditions":"Rhinitis Perennial","enrollment":100},{"nctId":"NCT01306721","phase":"PHASE3","title":"Fexofenadine HCL - Pseudoephedrine HCL Combination Versus Allegra in Patients With Seasonal Allergic Rhinitis","status":"COMPLETED","sponsor":"Sanofi","startDate":"2011-02","conditions":"Rhinitis Seasonal","enrollment":520}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"fexofenadine HCL (M016455)","genericName":"fexofenadine HCL (M016455)","companyName":"Sanofi","companyId":"sanofi","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Fexofenadine HCL is an antihistamine that works by blocking the action of histamine, a substance in the body that causes allergy symptoms. Used for Seasonal allergic rhinitis, Perennial allergic rhinitis.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}